MedPath

DIFLUNISAL-250 - TAB 250MG

DIFLUNISAL-250 - TAB 250MG

Discontinued
DIN Number

02130904

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

PRO DOC LIMITEE

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02130904
AIG Number0113161001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BA11 DIFLUNISAL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

DIFLUNISALActive
Strength: 250 MG / TAB
Monograph: DIFLUNISAL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.